Hospital of Venereal and Skin Diseases of Thessaloniki,Decentralized Organic Unit of GNTH IPPOKRATIO
- Address
- 124 Delphi Str, 54643 Thessaloniki, Greece
Hospital of Venereal and Skin Diseases of Thessaloniki - Dermatological Research Center
The Hospital of Venereal and Skin Diseases of Thessaloniki, operating as a Decentralized Organic Unit of GNTH IPPOKRATIO, is a specialized dermatological research institution dedicated to advancing treatment options for complex skin conditions. The center demonstrates particular expertise in investigating chronic inflammatory dermatoses and their therapeutic management through participation in innovative clinical trials.
- Hidradenitis suppurativa treatment research and novel therapeutic approaches
- Long-term safety evaluation of emerging dermatological therapies
- Clinical investigation of targeted immunomodulatory agents for chronic skin diseases
The research center focuses on evaluating povorcitinib, a selective oral treatment for moderate to severe hidradenitis suppurativa, participating in both primary efficacy studies and extended long-term safety evaluations. This commitment to comprehensive assessment, from initial efficacy determination through extended follow-up periods, reflects the institution's dedication to establishing both the therapeutic benefit and safety profile of innovative treatments for patients suffering from debilitating chronic inflammatory skin conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Incyte Corp.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital of Venereal and Skin Diseases of Thessaloniki,Decentralized Organic Unit of GNTH IPPOKRATIO
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa | Incyte Corp. | Phase III | Not Recruiting | Jun 2023 | Dec 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide | 2 | Unknown | 2023-06-15 | 2024-07-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.